Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116


The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.

Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N, Cantelmo AR, Franzi F, Capella C, Ferlazzo G, Mortara L, Albini A, Noonan DM.

Neoplasia. 2013 Feb;15(2):133-42.


Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.

Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, Ratto GB, Mingari MC, Moretta L, Ferlazzo G.

Cancer. 2008 Feb 15;112(4):863-75. doi: 10.1002/cncr.23239.


Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer.

Al Omar SY, Marshall E, Middleton D, Christmas SE.

Immunology. 2011 May;133(1):94-104. doi: 10.1111/j.1365-2567.2011.03415.x. Epub 2011 Feb 22.


Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.

LeFever AV, Funahashi A.

Cancer Res. 1991 Oct 15;51(20):5596-601.


Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.

Ciszak L, Kosmaczewska A, Werynska B, Szteblich A, Jankowska R, Frydecka I.

Oncol Rep. 2009 Jan;21(1):173-84.


Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma.

Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, Validire P, André P, Dieu-Nosjean MC, Alifano M, Régnard JF, Fridman WH, Sautès-Fridman C, Cremer I.

Cancer Res. 2011 Aug 15;71(16):5412-22. doi: 10.1158/0008-5472.CAN-10-4179. Epub 2011 Jun 27.


Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.

Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y, Vignaud JM.

J Lab Clin Med. 2002 Nov;140(5):320-8.


CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.

Gogali F, Paterakis G, Rassidakis GZ, Liakou CI, Liapi C.

Thyroid. 2013 Dec;23(12):1561-8. doi: 10.1089/thy.2012.0560. Epub 2013 Nov 6.


Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.

Barcelos W, Sathler-Avelar R, Martins-Filho OA, Carvalho BN, Guimarães TM, Miranda SS, Andrade HM, Oliveira MH, Toledo VP.

Scand J Immunol. 2008 Jul;68(1):92-102. doi: 10.1111/j.1365-3083.2008.02116.x. Epub 2008 May 14.


Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.

Esendagli G, Bruderek K, Goldmann T, Busche A, Branscheid D, Vollmer E, Brandau S.

Lung Cancer. 2008 Jan;59(1):32-40. Epub 2007 Sep 7.


Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.

Le Maux Chansac B, Missé D, Richon C, Vergnon I, Kubin M, Soria JC, Moretta A, Chouaib S, Mami-Chouaib F.

Int Immunol. 2008 Jul;20(7):801-10. doi: 10.1093/intimm/dxn038. Epub 2008 Apr 25.


Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.

Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW Jr, Chatterjee SK.

J Immunol. 2005 Oct 15;175(8):5541-50.


H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction.

Izawa S, Kono K, Mimura K, Kawaguchi Y, Watanabe M, Maruyama T, Fujii H.

Cancer Immunol Immunother. 2011 Dec;60(12):1801-10. doi: 10.1007/s00262-011-1082-7. Epub 2011 Aug 3.


TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells.

Keskin DB, Allan DS, Rybalov B, Andzelm MM, Stern JN, Kopcow HD, Koopman LA, Strominger JL.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3378-83. Epub 2007 Feb 20.


CD16- CD56+ natural killer cells after bone marrow transplantation.

Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE.

Blood. 1992 Jun 15;79(12):3239-44.


Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.

Bonnesen B, Pappot H, Holmstav J, Skov BG.

Lung Cancer. 2009 Dec;66(3):314-8. doi: 10.1016/j.lungcan.2009.02.013. Epub 2009 Mar 25.


Supplemental Content

Support Center